Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Daewon Pharmaceutical Co Ltd

+ Add to Watchlist

003220:KS

18,400 KRW 250 1.34%

As of 02:10:30 ET on 03/27/2015.

Snapshot for Daewon Pharmaceutical Co Ltd (003220)

Open: 18,750 Day's Range: 18,000 - 18,800 Volume: 84,281
Previous Close: 18,650 52wk Range: 9,619 - 19,200 1-Yr Rtn: +70.56%

Stock Chart for 003220

No chart data available.
  • 003220:KS 18,400
  • 1D
  • 1M
  • 1Y
18,650
Interactive 003220 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 003220

Current P/E Ratio (ttm) 25.3575
Estimated P/E(12/2015) 16.6697
Relative P/E vs. KOSPI 1.0440
Earnings Per Share (KRW) (ttm) 725.6236
Est. EPS (KRW) (12/2015) 1,103.8000
Est. PEG Ratio -
Market Cap (M KRW) 315,946.44
Shares Outstanding (M) 17.17
30 Day Average Volume 118,880
Price/Book (mrq) 2.5560
Price/Sale (ttm) 1.9656
Dividend Indicated Gross Yield 0.78%
Cash Dividend (KRW) 142.8571
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 1.15%
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 003220

No data available

Company Profile & Key Executives for 003220

Daewon Pharmaceutical Co., Ltd. manufactures and wholesales general and special drugs. The Company's product includes antipyretics, analgesics, respiratory, anti-inflammatory, and metabolic drugs. Daewon also produces health food products.

Baek Seung-HoChairman/Co-Rep DirectorBaek Seung-RyelVice Chairman/Co-Rep Director
Woo Yong-SooChief Executive OfficerPark Sun-KeunPresident
More Company Profile & Key Executives for 003220

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil